Advancements in the treatment of Inflammatory Bowel Disease (IBD) have significantly improved the quality of life for many patients. Within the therapeutic arsenal, Olsalazine Sodium (CAS 6054-98-4) holds a notable position, particularly in managing ulcerative colitis. Its unique mechanism of action and efficacy make it a subject of ongoing interest for pharmaceutical researchers and developers.

Olsalazine Sodium is a dimer of mesalamine (5-aminosalicylic acid), linked by an azo bond. This structure allows it to bypass the upper gastrointestinal tract and reach the colon, where colonic bacteria cleave the azo bond, releasing two molecules of mesalamine. This targeted release of the active anti-inflammatory agent is key to its therapeutic benefit in reducing colonic inflammation and ameliorating symptoms of ulcerative colitis. The precise formulation and quality of Olsalazine Sodium are therefore critical for its clinical performance.

For pharmaceutical companies engaged in IBD research and development, sourcing high-purity Olsalazine Sodium is a fundamental requirement. As a specialized manufacturer and supplier of pharmaceutical intermediates from China, we provide Olsalazine Sodium with 98% purity, ensuring that it meets the rigorous standards necessary for drug development and commercial production. Our product's physical characteristics, such as its appearance as a light yellow to off-white powder and its solubility profile, are meticulously controlled.

We understand the dynamic nature of pharmaceutical R&D and the need for reliable partners. Whether you are exploring new formulations, scaling up production, or seeking cost-effective procurement solutions, our company offers a dependable source for Olsalazine Sodium. We provide competitive pricing and flexible ordering options, making it easier for researchers and manufacturers to buy this essential compound.

By partnering with us, you gain access to a consistent supply of high-quality Olsalazine Sodium from a trusted Chinese manufacturer. We are committed to supporting innovation in IBD treatment by providing the critical ingredients needed. Connect with us today to learn more about our product and how we can fulfill your requirements for this important pharmaceutical intermediate.